Quick Answer
Nuo Therapeutics, Inc. reported Total Assets of $1.85 million for fiscal year 2025.
Nuo Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.85M | +55.2% |
| 2024 | $1.19M | -36.7% |
| 2023 | $1.88M | -38.4% |
| 2022 | $3.05M | +107.9% |
| 2021 | $1.47M | +877.7% |
| 2021 | $149.9K | -2.1% |
| 2021 | $153.1K | -2.7% |
| 2021 | $157.3K | -2.6% |
| 2020 | $161.4K | — |
| 2020 | $0.00 | -100.0% |
| 2020 | $13.00 | -99.9% |
| 2020 | $12.1K | -95.6% |
| 2019 | $276.5K | -71.7% |
| 2018 | $975.5K | -31.5% |
| 2017 | $1.42M | -89.9% |
| 2016 | $14.06M | +98.7% |
| 2015 | $7.07M | -87.4% |
| 2014 | $56.22M | +21.6% |
| 2013 | $46.25M | +4.3% |
| 2012 | $44.33M | +339.9% |
| 2011 | $10.08M | +13.2% |
| 2010 | $8.90M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.93M | +12.1% | +41.8% |
| June 30, 2025 | $1.36M | -4.3% | +18.6% |
| March 31, 2025 | $1.15M | -7.7% | -3.6% |
| December 31, 2024 | $1.19M | -36.7% | -30.8% |
| September 30, 2024 | $1.72M | +7.5% | +21.0% |
| June 30, 2024 | $1.42M | +2.5% | +14.3% |
| March 31, 2024 | $1.24M | -44.0% | -33.8% |
| December 31, 2023 | $1.88M | -38.4% | +17.4% |
- Nuo Therapeutics, Inc. showed an increase of +55.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Nuo Therapeutics, Inc.’s total assets has declined by 79.3% (from $8.90 million to $1.85 million).
- The most recent figure is from Nuo Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: